Skip to main content

Advertisement

Table 1 Characteristics of pregnant HIV-infected women, 1 May 2008 to 31 May 2009, McCord Hospital

From: A retrospective study of Human Immunodeficiency Virus transmission, mortality and loss to follow-up among infants in the first 18 months of life in a prevention of mother-to-child transmission programme in an urban hospital in KwaZulu-Natal, South Africa

Maternal characteristics N* n % 95% Confidence Intervals
Race 125    
Black (South African)   119 95.2 89.8 - 98.2
Asian   4 3.2 0.9 - 8.0
White   1 0.8 0.0 - 4.4
Black (other African)   1 0.8 0.0 - 4.4
Parity 247    
Primiparity   86 34.8 28.9 - 41.1
Multiparity   161 65.2 58.9 - 71.1
Maternal CD4 + count (cells/mm 3 ) 250    
< 200   68 27.2 21.8 - 33.2
200 – 499   147 58.8 52.4 - 65.0
≥ 500   35 14 9.9 - 18.9
Maternal antiretroviral regimen 258    
ART for life   128 49.6 43.4 - 55.9
PMTCT:     
Zidovudine, lamivudine. efavirenz from 28 weeks   85 32.9 27.2 - 39.0
Zidovudine from 28 weeks   40 15.5 11.3 - 20.5
sd-nevirapine + zidovudine and lamivudine for 7 days   4 1.6 0.4 - 3.9
Nevirapine only   1 0.4 0.0 - 2.1
Booking gestational age, weeks 246    
0-12   29 11.8 8.0 - 16.5
13-27   155 63.0 56.6 - 69.1
≥ 28   62 25.2 19.9 - 31.1
Any illness during pregnancy 247    
Yes   127 51.4 45.0 – 57.8
No   120 48.6 42.2 – 55.0
Pulmonary tuberculosis 127 12 9.4 5.0 -15.9
Mode of delivery 254    
Emergency C/S   74 29.1 23.6 - 35.1
Booked C/S   89 35.0 29.2 - 41.3
NVD   91 35.8 29.9 - 42.1
Maternal mortality 256    
No   255 99.6 97.8 – 100
Yes   1 0.4 0.0 - 2.2
  1. N* The number of mothers across categories of maternal characteristics may not add up to 258 due to missing data.